Celebrating India’s independence, enterprise and progress
news

Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones

Jan 10, 2025 · Source: cision
Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones

PANAJI, India, Jan. 10, 2025 -- Zlata Pharma LLP hosted a memorable event to mark the launch of its new wellness product range, marking a significant milestone. At the heart of the evening was the shared vision of positioning Goa prominently on India's pharmaceutical map, with a mission to establish Zlata Pharma as a key player in the healthcare sector over the next 3–5 years. Zlata Pharma's unveiling of its new product range marked a significant milestone.

The products include Pain Relief, a Balm for headaches and colds, a Spray for targeted relief on the back, neck, and joints, and a Gel for sprains and body aches. Additionally, Zlata is entering the Sexual Wellness category with the launch of Sambhog. As the company expands its footprint into new categories, Zlata will remain its flagship brand, embodying innovation and excellence in the healthcare sector.

The occasion was graced by Dr. Shri Shekhar Salkar, MS. FICS ONCO, along with Dr. Tarak Arolkar, Chairman, Zlata Pharma LLP, Mr. Harshad Sadvelkar, Managing Director, Zlata Pharma LLP, Mr. Rajesh Dalvi, Chief Executive Officer, Zlata Pharma, Mr. Amit Falari, Chief Finance Officer and Mr. Pratap Naik, Chief Operating Officer participated in a ceremonial lamp-lighting, embodying hope and the power of collective action.

Dr. Shri Shekhar Salkar, MS. FICS ONCO, praised Zlata Pharma's commitment to innovation and healthcare excellence Zlata Pharma's dedication to merging traditional wisdom with modern science is truly commendable. Their Pain Relief Range, reflects an unwavering commitment to improving lives across India. It is heartening to see a company born in Goa stepping forward with such innovation and purpose, creating solutions that resonate with the needs of millions. I am confident that Zlata Pharma will continue to set benchmarks in healthcare, making a meaningful impact not just in the state, but nationwide."

Shri Harshad Sadvelkar, Managing Director of Zlata Pharma, shared his excitement for the future. "We are incredibly excited about the future and the immense opportunities ahead. At Zlata Pharma, we are deeply committed to positioning Goa as a central hub for pharmaceutical innovation and cutting-edge research. Our goal is to not only generate high-quality employment across India but also to build a workforce that is as passionate and driven as we are. Our success will be measured by the impact we make on the healthcare sector and our ability to serve communities with trustworthy and effective solutions. This is not just a business initiative; it is a commitment to contributing meaningfully to India's healthcare landscape. As we grow, we aim to create a sustainable legacy that empowers both Goa and the nation."

Chairman of Zlata Pharma LLP Shri Tarak Arolkar stated, "Our journey is just beginning, and while the road ahead is full of challenges, our aspirations are clear and unwavering. Zlata Pharma is driven by a mission to make a real difference in the pharmaceutical industry, in Goa, and in the lives of those who place their trust in us. Our vision is one of long-term growth, where we continue to innovate and lead with purpose. Goa is not just where we do business – it's our home, our foundation, and the source of our values. As we look to expand nationally and globally, we are committed to staying true to our roots and building a company that reflects the spirit of this great state, while contributing to the broader healthcare narrative. We believe that our success will ultimately be a success for Goa, for India, and for all those who stand with us."

The gathering beautifully blended cultural pride, a commitment to innovation, and a shared vision of shaping a brighter future for the healthcare industry. As the guests lingered over conversations and a sumptuous dinner, one thing was clear – Zlata Pharma's launch was not just a milestone for the company but a step toward building a legacy that combines innovation, opportunity, and human connection. With its strong roots in Goa and a vision to impact healthcare on a national scale, Zlata Pharma is poised to not only make a mark in the industry but also inspire a sense of pride and purpose for the community it calls home.

About Zlata Pharma LLP

Zlata Pharma LLP, a newly incorporated company based in Goa, founded by a team of seasoned Goan industry professionals ventured into the highly competitive and fast-growing Pain Relief Category. The management is excited to announce the launch of its latest Pain Relief Range, composed to relieve millions of Indians from aches and pains of multiple types. This new product brings the age-old, tried and tested goodness of exceptional quality, and reliable relief. Zlata will be the flagship brand of the company going forward, as it expands its footprint into new categories.

Photo: https://mma.prnewswire.com/media/2595479/Product_Launch_Zlata_Pharma_LLP.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/goa-to-lead-in-pharma-growth-as-zlata-pharma-sets-industry-milestones-302348010.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research
news
Aug 11, 2026 1 min

Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research

Quarterly grant program provides researchers with no-cost access to Metabolon s industry-leading metabolomics platform, scientific expertise, bioinformatics tools, and data interpretation resources MORRISVILLE, N.C. , Aug. 11, 2026 -- Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostic, therapeutic, and precision medicine applications, today announced the launch of the Metabolon Peak Science Grant Program, a competitive quarterly grant designed to help researchers advance high-impact science through access to Metabolon s industry-leading metabolomics platform, analytical services, bioinformatics tools, data resources, and scientific expertise.

NYSE Content Update: Lumilens Tops $5.5 Billion Valuation After Latest Funding
news
Aug 11, 2026 1 min

NYSE Content Update: Lumilens Tops $5.5 Billion Valuation After Latest Funding

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK , Aug. 11, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today s NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on August 11th ICE Brent Crude approaches 90 a barrel as investors navigate the latest uncertainties in the Middle East. Lumilens CMO Mark Weiner will join NYSE Live to discuss how the AI infrastructure connectivity platform will capitalize on fresh funding. Announced Series C raise of more than 700 earlier this month. Latest funding brought its capital raised to over 900 million. JERi co-founders Ross Yellowlees and Emily Ward will join NYSE Live to explain how their new platform is designed to disrupt the status quo.

Blockchain for Good Alliance and Bybit Join the Mauritius Internet Governance Forum to Advance Digital Trust for Small Island States
news
Aug 11, 2026 1 min

Blockchain for Good Alliance and Bybit Join the Mauritius Internet Governance Forum to Advance Digital Trust for Small Island States

DUBAI, UAE , Aug. 11, 2026 -- Blockchain for Good Alliance (BGA) , the global non-profit initiative founded by Bybit, dedicated to leveraging blockchain for societal impact, took part in the Mauritius Internet Governance Forum, founded by the Halley Movement, contributing perspectives on how blockchain and emerging technologies can support an inclusive, secure, and trustworthy digital future for small island developing states (SIDS). The Mauritius Internet Governance Forum, recognised by the United Nations IGF Secretariat as a national IGF, convenes government, industry, academia, civil society, and youth in multistakeholder dialogue on the future of internet governance. This year s engagement centred on the themes of artificial intelligence, cybersecurity, and digital trust.

Green Cabbage Announces the Launch of the F&I (Finance & Insurance) Market Data Spend Cube
news
Aug 11, 2026 1 min

Green Cabbage Announces the Launch of the F&I (Finance & Insurance) Market Data Spend Cube

New Spend Cube Enables Global Companies to Negotiate Smarter Deals with F&I Suppliers PITTSBURGH , Aug. 11, 2026 -- Green Cabbage, the leading procurement intelligence partner for 2,600+ organizations across North America, EMEA, APAC, and LATAM, today announced the launch of its F&I (Finance & Insurance) Market Data Spend Cube. The F&I Spend Cube arms finance, procurement, and legal teams with independent market intelligence to identify spending patterns, eliminate overpayment, and unlock negotiation leverage across three critical spend categories: Market Data & Information Aggregators, Insurance & Financial Services Technology, and Financial Services Operations & Analytics.

IBM and Together AI Sign Multi-Year Agreement to Scale Open-Source AI Inference with NVIDIA AI Infrastructure on IBM Cloud
news
Aug 11, 2026 1 min

IBM and Together AI Sign Multi-Year Agreement to Scale Open-Source AI Inference with NVIDIA AI Infrastructure on IBM Cloud

First large-scale inference cluster with Together AI on IBM Cloud using NVIDIA HGX B300 systems to help enterprises run AI workloads, designed for fast and efficient production ARMONK, N.Y. and SAN FRANCISCO , Aug. 11, 2026 -- IBM (NYSE: IBM ) announced a collaboration with Together AI to deliver IBM and NVIDIA AI infrastructure. Under a multi-year 240M agreement between IBM and Together AI, IBM is positioned to deploy a large cluster of NVIDIA HGX B300 systems on IBM Cloud with expected availability in Q1 2027. Together AI will use this cluster to provide open-source model inference. This deployment is the first dedicated, large-scale cluster built for inference on IBM Cloud using HGX B300 systems and NVIDIA Spectrum - X TM Ethernet networking. According to NVIDIA, it is built to deliver 30x more AI factory output compared to prior generations.

Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
news
Aug 11, 2026 1 min

Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging

VueJect strengthens Bracco s integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging MILAN , Aug. 11, 2026 -- Bracco Imaging today announced that VueJect , its first dedicated ultrasound contrast delivery system engineered to support cardiology imaging specifically, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and authorization from Health Canada. These regulatory milestones represent the first step in Bracco s broader global commercialization strategy for VueJect, reinforcing the company s long-term commitment to advancing contrast-enhanced ultrasound (CEUS). VueJect will initially be available in the United States and Canada, with additional regulatory submissions planned in other markets.

AI's Growth Reveals a Hidden $4.63 Trillion Problem: Outdated and Unmanaged Enterprise Content
news
Aug 11, 2026 1 min

AI's Growth Reveals a Hidden $4.63 Trillion Problem: Outdated and Unmanaged Enterprise Content

The cost of content debt is greater than the GDP of Japan, the fourth-largest economy in the world NEW YORK , Aug. 11, 2026 -- New research from Storyblok , in collaboration with FT Longitude (part of The Financial Times), uncovers the true cost of content debt: content that is outdated, poorly structured, not optimized for search or AI discovery, and difficult to update and publish efficiently. According to a survey of organizations with at least 1 billion in annual global revenue, content debt is costing enterprises 4.63 trillion worldwide, based on spend devoted to fixing it and revenue at risk from it.

9Spokes Launches Pulse: Configurable Data & Insights for SMB Customers of Financial Service Providers
news
Aug 11, 2026 1 min

9Spokes Launches Pulse: Configurable Data & Insights for SMB Customers of Financial Service Providers

AUCKLAND, New Zealand , Aug. 11, 2026 -- 9Spokes , a leading global data platform, announced the launch of Pulse , a new intelligence layer within its SMB Financial Hub platform that delivers small business customers answers they cannot get from their bank app, accounting software, or merchant terminal alone. With AI raising the bar for how people expect to consume data, SMB owners now want plain-language answers, not static dashboards they want insights that explain what their data means and what to do about it. Pulse is built for that shift and for financial service providers who are not yet ready to implement customer-facing AI solutions but who recognize the shift.